B&K Corp Ltd is a CN-based company operating in industry. The company is headquartered in Qingdao, Shandong and currently employs 100 full-time employees. The company went IPO on 2025-12-22. B&K Corp Ltd is a China-based company principally engaged in the research and development of biopharmaceutical products. The firm committed to developing therapies with an emphasis on protein drugs for indications with medical needs and market opportunities. The firm primarily focus on the discovery, development and commercialization of therapies for wound healing, currently platelet-derived growth factor (PDGF) drugs. The firm mainly operates its businesses in the domestic market.